BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 22361769)

  • 1. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
    Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
    Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the β-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia.
    Marie MA; John J; Krishnappa LG; Gopalkrishnan S
    Microbiol Immunol; 2013 Dec; 57(12):805-10. PubMed ID: 24117831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of TaqMan real-time polymerase chain reaction for the detection of the newly emerging form of carbapenem resistance gene in clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.
    Manchanda V; Rai S; Gupta S; Rautela RS; Chopra R; Rawat DS; Verma N; Singh NP; Kaur IR; Bhalla P
    Indian J Med Microbiol; 2011; 29(3):249-53. PubMed ID: 21860104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
    Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.
    El-Herte RI; Araj GF; Matar GM; Baroud M; Kanafani ZA; Kanj SS
    J Infect Dev Ctries; 2012 May; 6(5):457-61. PubMed ID: 22610714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of integrons in clinical isolates of betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Iran.
    Zeighami H; Haghi F; Hajiahmadi F
    J Chemother; 2015 Jun; 27(3):145-51. PubMed ID: 24571248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
    Samra Z; Ofir O; Lishtzinsky Y; Madar-Shapiro L; Bishara J
    Int J Antimicrob Agents; 2007 Dec; 30(6):525-9. PubMed ID: 17931835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain.
    Tórtola MT; Lavilla S; Miró E; González JJ; Larrosa N; Sabaté M; Navarro F; Prats G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3492-4. PubMed ID: 16048967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
    Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
    Poulou A; Spanakis N; Pournaras S; Pitiriga V; Ranellou K; Markou F; Tsakris A
    J Antimicrob Chemother; 2010 Dec; 65(12):2538-42. PubMed ID: 20876622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.